[The role of sphingomyelin cycle and tumor necrosis factor alpha in toxic effect of beta-amyloid peptide].
Alesenko
A V
AV
Bugrova
A E
AE
Dudnik
L N
LN
Korobko
V G
VG
Shingarova
L N
LN
D000544:Alzheimer Disease / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000009:adverse effects*; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D002518:Ceramides / Q000096:biosynthesis; D002531:Cerebellum / Q000187:drug effects / Q000201:enzymology; D002855:Chromatography, Thin Layer / Q000295:instrumentation; D004195:Disease Models, Animal; D006624:Hippocampus / Q000187:drug effects / Q000201:enzymology; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D018384:Oxidative Stress / Q000187:drug effects; D051381:Rats; D017208:Rats, Wistar; D013108:Sphingomyelin Phosphodiesterase / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
D016229:Amyloid beta-Peptides; D002518:Ceramides; D014409:Tumor Necrosis Factor-alpha; D013108:Sphingomyelin Phosphodiesterase